Cargando…

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition

Long non-coding RNA-myocardial infarction-associated transcript (lncRNA-MIAT) has been reported to play an important role in the development of multiple cancers. However, the biological roles of MIAT in liver fibrosis are still unknown. In this study, the expression of MIAT is up-regulated during li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Yating, Tao, Qiqi, Meng, Qishan, Zhang, Rongrong, Lin, Lifan, Li, Xinmiao, Zheng, Lei, Zheng, Jianjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024685/ https://www.ncbi.nlm.nih.gov/pubmed/36934152 http://dx.doi.org/10.1038/s42003-023-04670-z

Ejemplares similares

Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway
por: Li, Chunxue, et al.
Publicado: (2021)

Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway
por: Zhou, Guangyao, et al.
Publicado: (2022)

20(S)- Protopanaxadiol suppresses hepatic stellate cell activation via WIF1 demethylation-mediated inactivation of the Wnt/β-catenin pathway
por: Li, Chunxue, et al.
Publicado: (2023)

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
por: Lang, Zhichao, et al.
Publicado: (2023)

LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease
por: Tan, Jin, et al.
Publicado: (2019)

lncRNA MIAT promotes cell invasion and migration in esophageal cancer
por: Zhang, Weiguo, et al.
Publicado: (2020)

Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure
por: Yang, Liu, et al.
Publicado: (2021)

Downregulation of lncRNA Miat contributes to the protective effect of electroacupuncture against myocardial fibrosis
por: Qi, Wenchuan, et al.
Publicado: (2022)

Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
por: Todoerti, Katia, et al.
Publicado: (2021)

Chlamydia trachomatis induces lncRNA MIAT upregulation to regulate mitochondria‐mediated host cell apoptosis and chlamydial development
por: Luo, Fangzhen, et al.
Publicado: (2021)

Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy
por: Wang, Ziyang, et al.
Publicado: (2022)

Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2023)

Ginsenoside Rg1 Epigenetically Modulates Smad7 Expression in Liver Fibrosis via MicroRNA-152
por: Zhang, Rongrong, et al.
Publicado: (2023)

Elevated lncRNA MIAT in peripheral blood mononuclear cells contributes to post-menopausal osteoporosis
por: Li, Rui, et al.
Publicado: (2022)

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212
por: Yu, Fujun, et al.
Publicado: (2018)

Correction: LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212
por: Yu, Fujun, et al.
Publicado: (2022)

Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer
por: Li, Chengxin, et al.
Publicado: (2023)

Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer
por: Xu, Hao, et al.
Publicado: (2020)

LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer
por: Ye, Ting, et al.
Publicado: (2021)

Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression
por: Ji, Ting‐Ting, et al.
Publicado: (2020)

High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer
por: Zheng, Xiangxiang, et al.
Publicado: (2016)

Catechin relieves hypoxia/reoxygenation‐induced myocardial cell apoptosis via down‐regulating lncRNA MIAT
por: Cong, Lin, et al.
Publicado: (2020)

Role of lncRNA MIAT/miR-361-3p/CCAR2 in prostate cancer cells
por: Feng, Tao, et al.
Publicado: (2022)

LncRNA MIAT Upregulates NEGR1 by Competing for miR-150-5p as a Competitive Endogenous RNA in SCIRI Rats
por: Wang, Zheng, et al.
Publicado: (2022)

M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma
por: Chen, Bo, et al.
Publicado: (2022)

Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma
por: Yang, XinJie, et al.
Publicado: (2021)

ADSC Exosomes Mediate lncRNA-MIAT Alleviation of Endometrial Fibrosis by Regulating miR-150-5p
por: Shao, Xiaowen, et al.
Publicado: (2021)

Loss of lncRNA-SNHG7 Promotes the Suppression of Hepatic Stellate Cell Activation via miR-378a-3p and DVL2
por: Yu, Fujun, et al.
Publicado: (2019)

Loss of lncRNA-SNHG7 Promotes the Suppression of Hepatic Stellate Cell Activation via miR-378a-3p and DVL2
por: Yu, Fujun, et al.
Publicado: (2020)

Curcumin attenuates lncRNA H19-induced epithelial-mesenchymal transition in tamoxifen-resistant breast cancer cells
por: Cai, Jiaqin, et al.
Publicado: (2021)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-β2
por: Ding, Xue, et al.
Publicado: (2023)

LncRNA MIAT enhances systemic lupus erythematosus by upregulating CFHR5 expression via miR-222 degradation
por: Zhang, Yali, et al.
Publicado: (2021)

Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma
por: Wang, Peipei, et al.
Publicado: (2021)

LncRNA MIAT can regulate the proliferation, apoptosis, and osteogenic differentiation of bone marrow-derived mesenchymal stem cells by targeting miR-150-5p
por: Wang, Fei, et al.
Publicado: (2022)

Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer
por: Wang, Mengwei, et al.
Publicado: (2021)

LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism
por: He, Xin-yu, et al.
Publicado: (2023)

HOTAIR lncRNA promotes epithelial–mesenchymal transition by redistributing LSD1 at regulatory chromatin regions
por: Jarroux, Julien, et al.
Publicado: (2021)

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
por: Tao, Chuming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h09hsms7m1d7mkle2jirceo444